Left Ventricular Ejection Fraction Predicts Severity of Posttraumatic Stress Disorder in Patients With Implantable

Hiroyuki Sawatari1, Tomoko Ohkusa2, Anita Rahamawati3

  • 1Department of Health Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Insights

Implantable cardioverter-defibrillator patients with impaired left ventricular ejection fraction (LVEF) may experience worse post-traumatic stress disorder (PTSD) symptoms. Lower LVEF is linked to increased PTSD severity, particularly in those with LVEF below 35%.

Area of Science:

  • Cardiology
  • Psychology
  • Medical Devices

Background:

  • Implantable cardioverter-defibrillators (ICDs) treat fatal arrhythmias but can lead to psychological distress, including post-traumatic stress disorder (PTSD), especially after experiencing shocks.
  • Factors influencing PTSD development in ICD patients remain underexplored.

Purpose of the Study:

  • To investigate the relationship between echocardiographic cardiac function parameters and psychological problems, specifically PTSD, in patients with ICDs.

Main Methods:

  • 128 outpatients with ICDs completed the Impact of Event Scale Revised (IES-R) questionnaire to assess PTSD.
  • Demographic and clinical data, including left ventricular ejection fraction (LVEF), were collected from medical records.

Main Results:

  • Female sex and impaired LVEF were associated with lower IES-R scores (indicating less PTSD) or the development of PTSD (P=0.01 and P=0.03).
  • Impaired LVEF significantly worsened PTSD symptoms of intrusion (P=0.02) and hyperarousal (P=0.03).
  • A negative correlation between LVEF and IES-R scores was observed in patients with LVEF <35% (P=0.045).

Conclusions:

  • Left ventricular ejection fraction (LVEF) is related to PTSD severity in ICD patients, particularly those with LVEF <35%.
  • Increased attention should be directed towards ICD patients with severely impaired left ventricular function to proactively manage psychological well-being.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
733